
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships
Frances Hendry | 19th May 2017
Anne Legendre reviews the scientific rationale behind immunotherapy combinations and Frances Hendry examines how partnerships, co-marketing and positioning drugs will play key roles in shaping the competitive landscape in oncology.
READ MORE